Research
Education
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Please note that all translations are automatically generated. Click here for the English version.
DOI :
10.3791/54845-v
•
10:30 min
December 8th, 2016
Chapters
0:05
Title
0:57
Preparation of Autologous Serum
2:20
Isolation of hMSCs from Bone Marrow
3:42
Culture of hMSCs in the Presence of Autologous Serum
5:19
Osteogenic Pre-induction and Recovery of hMSCs
6:20
Preparation of hMSCs/Fibrin Clot Constructs and Cell Viability Assay
7:30
Results: hMSCs/Fibrin Clot Generation and Application
9:10
Conclusion
自己血清を用いたヒト間葉系幹細胞(hMSCが)を培養し、異種材料と他の負の効果により拒絶反応のリスクを低減します。また、新鮮なのhMSCを配信することができ、中胚葉前駆細胞のサブセットを回収することができます。自家フィブリン塊でのhMSCの埋め込みは、取り扱いが容易で効果的な外科的移植を可能にします。
Tags
-- Views
Related Videos
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit
Librarians
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
ABOUT JoVE
Leadership
Copyright © 2024 MyJoVE Corporation. All rights reserved